Cvs Health (CVS) Invested Capital (2009 - 2026)

Cvs Health has reported Invested Capital for 18 years, with the latest figure at $80.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 1.6% year-over-year to $80.2 billion; the trailing twelve-month figure through Mar 2026 stood at $80.2 billion (down 1.6% YoY), and the FY2025 full-year result was $139.8 billion, down 1.56% from the prior year.
• Invested Capital for Q1 2026 stood at $80.2 billion, down from $139.8 billion in the prior quarter.
• The five-year high for Invested Capital was $142.0 billion in Q4 2024, with the low at $72.9 billion in Q3 2022.
• Historically, Invested Capital has averaged $109.7 billion across 5 years, with a median of $124.0 billion in 2022.
• Annual changes were most pronounced in 2023 — Invested Capital soared 87.27% — and 2025, when it slumped 40.83%.
• Cvs Health's Invested Capital stood at $124.0 billion in 2022, then rose by 11.47% to $138.2 billion in 2023, then increased by 2.72% to $142.0 billion in 2024, then fell by 1.56% to $139.8 billion in 2025, then slumped by 42.61% to $80.2 billion in 2026.
• The last three Invested Capital figures came in at $80.2 billion (Q1 2026), $139.8 billion (Q4 2025), and $138.8 billion (Q3 2025), per Business Quant data.